Dr. Michael D. Woolman, MD
Family Medicine (Family Medicine Physician)
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
UT license 163657-1205
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 1 companies reported 25 payments worth $2,142 in total to this clinician.
| Eli Lilly and Company | $2,142 |
|---|
| Travel and Lodging | $2,106 |
|---|---|
| Education | $36.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, GA · in-kind | $378 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $218 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $197 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, UT · in-kind | $188 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $104 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $98.00 |
| Eli Lilly and Company Apr 16, 2025 | Education in-kind | $36.00 |
All 25 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, GA · in-kind | $378 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $218 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $197 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, UT · in-kind | $188 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $104 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $98.00 |
| Eli Lilly and Company Apr 16, 2025 | Education in-kind | $36.00 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $32.37 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $17.43 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $17.43 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $16.97 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $15.30 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $14.94 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $14.94 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $11.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $8.10 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $7.65 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $2.49 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $0.82 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 11 industry-funded studies in 2025, from 3 companies. The companies reported $777,795 in research payments for these studies, mostly to the institutions running them.
- A master protocol to investigate the efficacy and safety of orforglipron once daily in participants with hypertension and obesity or overweight: randomized, double-blind, placebo-controlled trials (attain-hypertension…
Eli Lilly and Company - A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
Eli Lilly and Company · Completed · NCT05929079 - A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Eli Lilly and Company · Completed · NCT05929066 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
AbbVie Inc. · Active, not recruiting · NCT06417775 - A Phase II Randomised Double blind Placebo controlled Study to Evaluate the Efficacy Safety and Tolerability of AZD5004 in Participants living with Obesity or Overweight with Comorbidity
AstraZeneca Pharmaceuticals LP - A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
Eli Lilly and Company · Active, not recruiting · NCT05556512 - A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Eli Lilly and Company · Completed · NCT05882045 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
AbbVie Inc. - A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Eli Lilly and Company · Completed · NCT04255433 - M21-465 - Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASD
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.